Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Tax withholdingCommon Stock | 4,584 | $128.18 | $587,577.12 |
DisclosureSEC source: 0001225208-18-002812 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,071.3468 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionCommon Stock | 13,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002812 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,655.3468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 5,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002813 · doc4.xml · derivative · entry 8 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,953 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F2 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Ullmann Michael HExec VP, General Counsel
|
Tax withholdingCommon Stock | 2,052 | $128.18 | $263,025.36 |
DisclosureSEC source: 0001225208-18-002813 · doc4.xml · nonDerivative · entry 5 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,204.882 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionCommon Stock | 5,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002813 · doc4.xml · nonDerivative · entry 4 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,256.882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionRestricted Share Units · Derivative | 2,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002814 · doc4.xml · derivative · entry 5 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Kapusta Ronald AController, CAO
|
Tax withholdingCommon Stock | 795 | $128.18 | $101,903.10 |
DisclosureSEC source: 0001225208-18-002814 · doc4.xml · nonDerivative · entry 2 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,871 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionCommon Stock | 2,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002814 · doc4.xml · nonDerivative · entry 1 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:21 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Exercise / conversionRestricted Share Units · Derivative | 32,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002184 · doc4.xml · derivative · entry 3 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 2, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F3 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 2, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:21 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Tax withholdingCommon Stock | 17,296 | $138.88 | $2,402,068.48 |
DisclosureSEC source: 0001225208-18-002184 · doc4.xml · nonDerivative · entry 2 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,392 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 02, 2018 Filed Feb 6, 2018 21:21 UTC |
Mesquita Jorge S.Exec VP, WW Chair, Consumer
|
Exercise / conversionCommon Stock | 32,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002184 · doc4.xml · nonDerivative · entry 1 Mesquita Jorge S. · CIK 0001547344 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| January 05, 2018 Filed Feb 13, 2018 23:55 UTC |
Ullmann Michael HExec VP, General Counsel
|
GiftCommon Stock | 179 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002813 · doc4.xml · nonDerivative · entry 3 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,303.882 F1 · shares: Gift Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 22:50 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 353.746 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018690 · doc4.xml · derivative · entry 3 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,831.559 Underlying: Common Stock · 353.746 shares Expires not disclosed F2 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 22:50 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 282.961 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018691 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,873.3353 Underlying: Common Stock · 282.961 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 22:50 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 325.325 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018692 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,049.247 Underlying: Common Stock · 325.325 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| December 04, 2017 Filed Feb 13, 2018 23:54 UTC |
Gorsky AlexChairman, CEO
|
GiftCommon Stock | 7,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002810 · doc4.xml · nonDerivative · entry 1 Gorsky Alex · CIK 0001453149 · Chairman, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,825 F1 · price: Gift Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 21:01 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionRestricted Share Units · Derivative | 75,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-016825 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,492 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on October 31, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F2 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on October 31, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 21:01 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Tax withholdingCommon Stock | 34,742 | $139.54 | $4,847,898.68 |
DisclosureSEC source: 0001225208-17-016825 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,400.416 F1 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 21:01 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionCommon Stock | 75,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-016825 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,142.416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2017 Filed Dec 14, 2017 22:50 UTC |
PEREZ WILLIAM DDirector
|
GiftCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018690 · doc4.xml · nonDerivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 9,100 F1 · price: Gift. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 22:24 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 373.526 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015031 · doc4.xml · derivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,477.813 Underlying: Common Stock · 373.526 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 22:24 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 298.782 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015032 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,590.3743 Underlying: Common Stock · 298.782 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 22:24 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 343.515 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-015033 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,723.922 Underlying: Common Stock · 343.515 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 15:49 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 102,692 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-17-012890 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 102,692 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 15:49 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
SaleCommon Stock | 102,692 | $133.14 | $13,672,628.53 |
DisclosureSEC source: 0001225208-17-012890 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,650.416 F1 · price: This transaction was executed in multiple trades at prices ranging from $133.00 to $133.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 15:49 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
Exercise / conversionCommon Stock | 102,692 | $72.54 | $7,449,277.68 |
DisclosureSEC source: 0001225208-17-012890 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,342.416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 15:06 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 82,591 | $0.00 Strike: $61.75 | $0.00 |
DisclosureSEC source: 0001225208-17-012818 · doc4.xml · derivative · entry 5 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 82,591 shares Expires 2018-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 15:06 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
SaleCommon Stock | 82,591 | $136.72 | $11,291,478.12 |
DisclosureSEC source: 0001225208-17-012818 · doc4.xml · nonDerivative · entry 2 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,102 F1 · price: This transaction was executed in multiple trades at prices ranging from $136.715 to $136.745. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 20, 2017 Filed Jul 24, 2017 15:06 UTC |
Caruso Dominic JExec VP, Finance; CFO
|
Exercise / conversionCommon Stock | 82,591 | $61.75 | $5,099,994.25 |
DisclosureSEC source: 0001225208-17-012818 · doc4.xml · nonDerivative · entry 1 Caruso Dominic J · CIK 0001385325 · Exec VP, Finance; CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:34 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 372.99 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-011354 · doc4.xml · derivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,104.287 Underlying: Common Stock · 372.99 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:34 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 298.353 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-011355 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,291.5923 Underlying: Common Stock · 298.353 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:34 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 343.022 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-011356 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,380.407 Underlying: Common Stock · 343.022 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| May 10, 2017 Filed Feb 13, 2018 23:55 UTC |
Ullmann Michael HExec VP, General Counsel
|
GiftCommon Stock | 409 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002813 · doc4.xml · nonDerivative · entry 2 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,482.882 F1 · shares: Gift Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:54 UTC |
PEREZ WILLIAM DDirector
|
GrantDeferred Share Units · Derivative | 379.689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-006426 · doc4.xml · derivative · entry 1 PEREZ WILLIAM D · CIK 0001184649 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,731.297 Underlying: Common Stock · 379.689 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:54 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 304.274 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-006427 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,993.2393 Underlying: Common Stock · 304.274 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:54 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 350.16 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-006428 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,037.385 Underlying: Common Stock · 350.16 shares Expires not disclosed F1 · derivative.exercise_price: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: The Deferred Share Units acquired, and dividends accrued, under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's Retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 20,842 | $0.00 Strike: $61.75 | $0.00 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · derivative · entry 6 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,842 shares Expires 2018-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 29,158 | $0.00 Strike: $58.33 | $0.00 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,130 Underlying: Common Stock · 29,158 shares Expires 2019-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
SaleCommon Stock | 50,000 | $123.62 | $6,181,140.00 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,536 F1 · price: This transaction was executed in multiple trades at prices ranging from $123.35 to $123.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionCommon Stock | 20,842 | $61.75 | $1,286,993.50 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 21:21 UTC |
Duato JoaquinExec VP, WW Chair, Pharma
|
Exercise / conversionCommon Stock | 29,158 | $58.33 | $1,700,786.14 |
DisclosureSEC source: 0001225208-17-005738 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Exec VP, WW Chair, Pharma 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,694 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:16 UTC |
Pruden Gary JExec VP, WW Chair, Med Devices
|
SaleCommon Stock | 16,299 | $122.21 | $1,991,943.17 |
DisclosureSEC source: 0001225208-17-005371 · doc4.xml · nonDerivative · entry 1 Pruden Gary J · CIK 0001673416 · Exec VP, WW Chair, Med Devices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,630.4236 F1 · price: This transaction was executed in multiple trades at prices ranging from $122.16 to $122.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:50 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 14,543 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-17-005403 · doc4.xml · derivative · entry 5 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,544 Underlying: Common Stock · 14,543 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Vested and exercisable one day after the third anniversary of the date of the grant. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:50 UTC |
Kapusta Ronald AController, CAO
|
SaleCommon Stock | 14,543 | $122.26 | $1,777,954.47 |
DisclosureSEC source: 0001225208-17-005403 · doc4.xml · nonDerivative · entry 2 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,964 F1 · price: This transaction was executed in multiple trades at prices ranging from $122.25 to $122.285. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:50 UTC |
Kapusta Ronald AController, CAO
|
Exercise / conversionCommon Stock | 14,543 | $72.54 | $1,054,949.22 |
DisclosureSEC source: 0001225208-17-005403 · doc4.xml · nonDerivative · entry 1 Kapusta Ronald A · CIK 0001654212 · Controller, CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2017 Filed Feb 13, 2018 23:55 UTC |
Ullmann Michael HExec VP, General Counsel
|
GiftCommon Stock | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002813 · doc4.xml · nonDerivative · entry 1 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,891.882 F1 · shares: Gift Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 23:53 UTC |
Stoffels PaulusExec VP, Chief Scientific Off
|
SaleCommon Stock | 22,000 | $117.29 | $2,580,274.40 |
DisclosureSEC source: 0001225208-17-003623 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,650.416 F1 · price: This transaction was executed in multiple trades at prices ranging from $117.23 to $117.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 02:59 UTC |
Beckerle Mary CDirector
|
GrantDeferred Share Units · Derivative | 1,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003481 · doc4.xml · derivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,186.811 Underlying: Common Stock · 1,512 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 02:59 UTC |
DAVIS D SCOTTDirector
|
GrantDeferred Share Units · Derivative | 1,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003482 · doc4.xml · derivative · entry 1 DAVIS D SCOTT · CIK 0001227733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,801.351 Underlying: Common Stock · 1,512 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 02:59 UTC |
Davis IanDirector
|
GrantDeferred Share Units · Derivative | 1,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003483 · doc4.xml · derivative · entry 1 Davis Ian · CIK 0001494009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,632.576 Underlying: Common Stock · 1,512 shares Expires not disclosed F1 · security: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon the Reporting Person's retirement (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.